Rhenman & Partners Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,850
| Closed | -$2.74M | – | 96 |
|
|
2024
Q4 | $2.74M | Sell |
14,850
-22,650
| -60% | -$4.18M | 0.28% | 72 |
|
|
2024
Q3 | $7.39M | Buy |
37,500
+3,500
| +10% | +$689K | 0.6% | 54 |
|
|
2024
Q2 | $7.02M | Buy |
34,000
+21,300
| +168% | +$4.4M | 0.67% | 43 |
|
|
2024
Q1 | $3.44M | Sell |
12,700
-25,300
| -67% | -$6.86M | 0.33% | 61 |
|
|
2023
Q4 | $8.98M | Sell |
38,000
-6,000
| -14% | -$1.42M | 0.9% | 42 |
|
|
2023
Q3 | $8.62M | Buy |
+44,000
| New | +$8.62M | 0.93% | 37 |
|